Startups
Overview
Location
United Kingdom, Scotland, Preston
Employees
11-50
Total raised
$45M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 11, 2014 | Spinifex Pharmaceuticals Raises $45M in Series C Funding | Spinifex Pharmaceuticals, a Melbourne, Australia- and Stamford, Connecticut-based biotechnology company developing new drug candidates for the treatment and management of pain, raised $45m in Series C funding. The round was led by Novo with... |
| Aug 23, 2011 | Spinifex Pharmaceuticals Raises AU$6.25M in expanded Series B Funding | Spinifex Pharmaceuticals, a Melbourne, Australia-based pain drug development company, has raised an additional AU$6.25m in an expanded Series B venture capital funding. Investors include GBS Venture Partners Limited, Brandon Capital Partner... |
Reviews 0
FAQ about Spinifex Pharmaceuticals
How much funding has Spinifex Pharmaceuticals raised?
Spinifex Pharmaceuticals has raised $45M in total across 1 funding round.
What has the press written about Spinifex Pharmaceuticals?
Parsers VC has collected 3 articles mentioning Spinifex Pharmaceuticals, among them “Spinifex Pharmaceuticals Raises $45M in Series C Funding” (Apr 11, 2014) and “Spinifex Pharmaceuticals Raises AU$6.25M in expanded Series B Funding” (Aug 23, 2011).
Is Spinifex Pharmaceuticals still active?
Spinifex Pharmaceuticals is probably closed: its latest activity on Parsers VC dates from Apr 11, 2014.